Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Harnessing Advances for Improving Exome

Date: Wednesday, April 24, 2019

Description: Drs Karbassi and Mullen discuss the value of exome testing in clinical practice and the clinical value of a high-quality exome and expert variant interpretation. At the conclusion of this program, participants will be able to: • Illustrate the role of exome testing in clinical practice and the economic value to the patient and health system • Describe the clinical value of high-quality depth of coverage and the inclusion of mitochondrial and CNV analysis in exome testing • Discuss the importance of expert human variant interpretation with knowledge-based automation in defining the quality of exome test results ASCLS P.A.C.E.® credits are available to laboratory professionals through October 23, 2019.

Authors:
Karbassi, Izabela, PhD, FACMG
Director of Science Variant IQ
Quest Diagnostics
Marlborough, MA

Mullen, Thomas, PhD, FACMG
Senior Director of Science, R&D and Genomics
Quest Diagnostics
Marlborough, MA

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.